The FDA’s accelerated approval process: When drugs are cleared for sale based on limited evidence
…Approval program to expedite the availability of new drugs that address an otherwise unmet medical need. This allows the FDA to approve drugs quickly by relying on a surrogate endpoint,…
Expert Commentary